glutathione mutations in sclc patients

glutathione mutations in sclc patients vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Differential KEAP1/NRF2 mediated signaling widens

Name: glutathione mutations in sclc patients vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Differential KEAP1/NRF2 mediated signaling widens
Brand: condeoeiras.edu.pt
SKU: 37428536560
Price: 20.77 USD
Availability: InStock
Rating: 4.7605 (28 reviews)

Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D MLL2: CALGB 151111 (Alliance) ScienceDirect Glutathione Dependent Pathways in Cancer Cells Oncology Reports Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review Journal of Clinical Oncology The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat?

SKU: 37428536560 · From condeoeiras.edu.pt

4.8

USD20.77 USD46.77

Pay in 4 interest-free payments of $5.19 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

Cell 130(6):10051018

Generative model utilizing deep learning De novo molecular design, which involves the proposal of previously unidentified compounds with desired properties, poses a formidable challenge in drug discovery and materials engineering